Biopta wins £575,000 drug testing boost
Wide Blue 20 November 2004
Wideblue client Biopta, the Glasgow-based life sciences company, has raised £575,000 in first-round funding to speed up the development of its state-of-the-art drug testing systems.
Wideblue client Biopta, the Glasgow-based life sciences company, has raised £575,000 in first-round funding to speed up the development of its state-of-the-art drug testing systems.